作者：
Mark H,Yazer [1]
;
Beth,Shaz [2]
;
Jansen N,Seheult [3]
;
Torunn O,Apelseth [1]
;
Dirk,de Korte [2]
;
Gerry,Devin [4]
;
Dana,Devine [5]
;
Cheryl,Doncaster [6]
;
Stephen,Field [7]
;
Peter,Flanagan [7]
;
Julie,Huet [6]
;
Alfredo,Mendrone [8]
;
Cath,O'Brien [9]
;
Joanne,Pink [10]
;
Mark,Rashleigh [11]
;
Eilat,Shinar [12]
;
Minoko,Takanashi [12]
;
Eka,Tian [13]
;
Pierre,Tiberghien [14]
;
Karin,van den Berg [12]
;
Colby,Schmitt [9]
作者单位：
Department of Pathology, University of Pittsburgh, Pittsburgh, PA, USA.
[1]
Vitalant, Pittsburgh, PA, USA.
[2]
New York Blood Center, New York, NY, USA.
[3]
Department of Immunology and Transfusion Medicine, Haukeland University Hospital, Bergen, Norway.
[4]
Department Product and Process Development, Sanquin Blood Bank, Amsterdam, The Netherlands.
[5]
Irish Blood Transfusion Service, Dublin, Ireland.
[6]
Canadian Blood Services, Ottawa, ON, Canada.
[7]
New Zealand Blood Service, Auckland, New Zealand.
[8]
Etablissement Français du Sang, Saint-Denis, France.
[9]
Fundação Pró-Sangue Hemocentro de São Paulo, São Paulo, Brazil.
[10]
Welsh Blood Service, Cardiff, UK.
[11]
Australian Red Cross Blood Service, Melbourne, VIC, Australia.
[12]
Magen David Adom, National Blood Services, Ramat Gan, Israel.
[13]
Japanese Red Cross, Tokyo, Japan.
[14]
South African National Blood Service, Port Elizabeth, South Africa.
[15]
DOI
10.1111/vox.12917
PMID
32281137
发布时间
2021-03-15
换一批
换一批
